Session Three of Defeat Duchenne Canadian Conference Addressing Standards of Care in Canada to Take Place December 3rd and 4th

The NMD4C is proud to partner with Jesse’s Journey and Muscular Dystrophy Canada (MDC) in hosting the first national summit solely focused on DMD for health care providers across Canada, with the theme for this year’s event being ‘Addressing DMD Standards of Care in Canada’. We have brought together subject matter experts from pediatric and adult care for a comprehensive overview of the Canadian adaptation to the international DMD care considerations published in 2018.

Don’t forget to register for the third and final session of the CPD-accredited Defeat Duchenne Canadian Conference, which will take place on the 3rd and 4th of December, 2021 with sessions on Orthopedic Management and Rehabilitation Management in Duchenne on December 3rd, and Psychosocial Management and Duchenne and the Brain on December 4th.

Thank you to everyone from our community who completed the pre-event Canadian Duchenne standards of care survey. The results from the survey will be used as a springboard for discussion during the event and prepared for publication thereafter. We hope to see you at the conference!

Register for session three here!

 

 

Day 1: Friday, December 3, 2021

11 a.m. – 12:30 p.m. ET: Orthopedic Management in Duchenne

Moderator:

Co-Leads/Speakers:

  • Dr. Chris Reilly (Pediatric Orthopedic Surgeon)
  • Dr. Patricia Larouche (Pediatric Orthopedic Surgeon)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in orthopedic management across Canada.
  • Understand lived experience of orthopedic care from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care for orthopedic care.

 

12:30 – 2 p.m. ET: Rehabilitation Management in Duchenne

Moderator:

Co-Leads/Speakers:

  • Dr. Sue Dojeiji (Adult Physiatrist)
  • Dr. Jordan Sheriko (Medical Director of Pediatric Rehabilitation)

Speakers:

  • Dr. Anna McCormick (Pediatrician & Pediatric Physiatrist)
  • Charise MacDonald (Occupational Therapist)
  • Dr. Michael Berger (Adult Physiatrist)

Panelists:

  • Sarah Moore (Recreational Therapist)
  • Khalid Mahdi (DMD Adult)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in rehabilitation management.
  • Understand lived experience of rehabilitation services from people with Duchenne and their families.
  • Participate in insightful discussions to identify and provide recommendations on how to address current gaps in Duchenne standards of care in rehabilitation management.

 

Day 2: Saturday, December 4, 2021

11 a.m. – 12:30 p.m. ET: Duchenne and the Brain

Moderator/Lead:

Speakers:

  • Dr. Francesco Muntoni (Professor Pediatric Neurology) – Keynote Speaker
  • Dr. Veronica Hinton (Professor of Psychology)

Panelists:

  • Debra Chiabai (DMD Parent)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care involving the brain across Canada.
  • Understand lived experience involving the brain from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care involving the brain.

 

12:30 – 2 p.m. ET: Psychosocial Management

Moderator:

Co-Leads/Speakers:

  • Dr. Jean Mah (Pediatric Neurologist)
  • Dr. Stephanie Plamondon (Adult Physiatrist)

Panelist:

  • Debra Chiabai (DMD Parent)
  • Zoe Schwartz (Pediatric Social Worker)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in psychosocial management across Canada.
  • Understand lived experience of psychosocial management from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care for psychosocial management.
DDCC21_speakers_poster

Read next...

2024 Dr David Green Award winners from MDC

NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards

We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.

NMD4C logo with text reading 'Canadian neuromuscular clinical trials network', MDC and IMHA logos at bottom.

NMD4C Launch Canadian Neuromuscular Clinical Trial Network

We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.

Event organizers and participants from SMA outcome measures training, March 2024 in Quebec.

Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network

This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted. 

MDC award $900 000 towards clinical and translational research projects in 2024.

MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants

Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.

SMA outcome measures training graphic

SMA Outcome Measures Training for Physiotherapists and Occupational Therapists

To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.

Congratulations to the 2024 early career award winners. Dr Mireille Khacho and Dr Jean-Philippe Leduc Gaudet.

Congratulations to the 2024 NMD4C Early Career Awards Recipients

We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.